LMAT250117C135000
- 0.00
- 0.000.00%
LeMaitre Vascular Newsroom
Declining Stock and Solid Fundamentals: Is The Market Wrong About LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
A Look At The Intrinsic Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
LeMaitre Vascular: Estimates Net Proceeds From Offering to Be Approximately $145.9M >LMAT
LeMaitre Vascular: Sale of Notes Scheduled to Settle on Dec. 19 >LMAT
LeMaitre Vascular: Intends to Use Proceeds for Working Capital, Potential Acquisitions or Investments in Complementary Companies, Product Lines, Products or Technologies >LMAT
Lake Street Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $105
Analysts Offer Insights on Healthcare Companies: Lemaitre Vascular (LMAT) and Qiagen (QGEN)
LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering
Express News | LeMaitre Vascular Inc - to Offer $150 Million Convertible Senior Notes Due 2030
LeMaitre Vascular (NASDAQ:LMAT) Sheds 5.5% This Week, as Yearly Returns Fall More in Line With Earnings Growth
LeMaitre to Participate at Upcoming Investor Conferences in December
Oppenheimer's Top Buy and Sell Ideas From Each of the Sectors
Should You Be Adding LeMaitre Vascular (NASDAQ:LMAT) To Your Watchlist Today?
What LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) 26% Share Price Gain Is Not Telling You
With EPS Growth And More, LeMaitre Vascular (NASDAQ:LMAT) Makes An Interesting Case
LeMaitre Vascular | 10-Q: Q3 2024 Earnings Report
LeMaitre Vascular Third Quarter 2024 Earnings: Beats Expectations
A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $93 to $105